Streptococcal Infections (S. pyogenes
Group A streptococci)
Reading Assignments: (1) Text Chapters 12, (2) HANDOUT: Cunha,
B. 1999. Patients 35, 36, 37, In: Infectious Disease Pearls,
Hanley and Belfus, Inc., Philadelphia, PA., (3) Gilligan, P.H.,
M.L. Smiley, and D.S. Shapiro. 1997. Cases in Medical Microbiology
and Infectious Diseases (2nd ed.), pp. 292-295.
American Society for Microbiology, Washington, D.C., (4) Low,
D.E., B. Schwartz, and A. McGeer. 1998. The Reemergence of Severe
Group A Streptococcal Disease: an Evolutionary Perspective, pp.
106-112. In: Scheld, W.M, D. Armstrong, and J.M. Hughes (eds.) Emerging
Infections 1. ASM Press, Washington, D.C.
- INTRODUCTION
Streptococci are Gram positive spherical or ovoid cells,
arranged in chains or pairs. The genus includes 37
species all of which are obligate parasites of
mucosal membranes (and for some, the tooth surfaces of
humans and animals). It includes both commensal
microflora on the mucosal membranes of the upper
respiratory, intestinal and genital tracts of humans
(many of which are opportunistic pathogens) and true
pathogens. The type species is S. pyogenes.
- CLASSIFICATION OF STREPTOCOCCI (three ways):
- Hemolysis Pattern (on blood agar)
1. beta hemolysis
2. alpha hemolysis
3. gamma hemolysis
- Lancefield group Serologically grouped according
to their major cell- wall carbohydrate antigen
- Species grouped based on metabolic reactions in
culture media
- GROUP A STREPTOCOCCUS (S. pyogenes)
- Group A Strep Virulence Factors
- Cell Surface Structures
- Hyaluronic Acid Capsule
- antiphagocytic
- nonimmunogenic "a
self-antigen"
- The M protein the major
virulence factor
- The ability of S.
pyogenes to persist in
infected tissues is due
to the cell
surface-exposed M
protein, a molecule which
allows it to resist
phagocytosis by
neutrophils (in the
absence of specific
antibodies)
- It is required for
virulence. Bacteria
lacking the M protein are
readily opsonized by
complement (via the
alternative pathway), are
phagocytosed, and
destroyed. Those with the
M protein cannot be
opsonized by complement
(generated by the
alternative pathway).
- The host must produce
antibodies specific for
the M protein in order to
opsonize and destroy this
pathogen
- Recent studies indicate
the M protein is not an
adhesin
- There are 100 different
serotypes of M proteins,
and individuals may
suffer recurrent
infections with different
serotypes of the M
protein. Certain M types
area associated with
invasive disease,
rheumatic fever, and
glomerulonephritis.
(Anti-M antibody is type
specific.)
- Structure -an alpha
helical fibrillar
molecule made up of 500
amino acids with its
carboxy terminal rooted
in the peptidoglycan of
the cell wall and the
amino terminal region
extending toward the
surface. Two fibrils of M
protein wind together to
make up the molecule on
the surface of the
bacterium. Fibrils
protrude up to 200 nm
from the cell surface.
- Individual M protein
molecules are composed of
several sequence repeat
regions designated by
capital letters (A, B,
C). There is variability
in the sequence of the N
terminal half of the
molecule and diversity in
this area of the molecule
is generated by
recombination and
horizontal gene transfer
involving related genes.
(The tip of the molecule
is a region of
hypervariablilty and
antibodies against this
region effectively
opsonize group A
streptococci for
phagocytosis.) The
C-terminal half of the
molecule, which includes
the wall-spanning region,
is more conserved.
- Different areas of the M
protein molecule help
this pathogen escape
phagocytosis by avoiding
opsonization with
complement :
- Distal portion of the
molecule - binds
fibrinogen shielding the
pathogen from complement
deposition. (As your book
points out, luckily, the
tips of the M protein
molecule protrude past
the fibrinogen coat, so
that antibody can oponize
the pathogen)
- Proximal portion of
the molecule binds
factor H, a protein that
inhibits the C3
convertase from cleaving
C3 into C3a and C3b. With
high concentrations of
factor H bound to the
bacterial cell surface
any C3 convertase that
forms on the cell surface
is quickly destroyed.
- Some M proteins
have receptors for other
serum proteins including
human fibrinogen, B2
microglobulin, the Fc
portion of IgG, and serum
albumin. Presumed
function immune
cloaking.
- M proteins share sequence
homology with a number of
mammalian proteins. Ex.
M5, M6, M12, and M24
proteins share 30%
sequence homology with
myosin proteins. This
cross reactivity may
explain the pathogenesis
of rheumatic fever (see
below).
- M-like Surface Proteins
- Structural and sequence
similarities to M
proteins. Like M proteins
they are embedded in the
bacterial cell wall via
the carboxy terminal end
with their amino terminal
ends exposed on the
bacterial sruface.
- Many bind the Fc portions
of IgG and IgA (can bind
nonspecifically to
antibodies not directed
against their own
surfaces). This coats the
bacteria with a layer of
host proteins and
"cloaks them"
(makes them less visible)
to complement and the
immune system.
- Like M proteins, some
M-like proteins bind
other host proteins
including fibrinogen,
fibronectin, human serum
albumin, alpha 2
macroglobulin, or factor
H. Function hiding
from the immune system.
- The distinction between M
proteins and M-like
proteins is not always
clear.
- Protein F (Fibronectin binding
protein) - Mediates adhesion to
fibronectin-coated epithelial
cells.
- Lipoteichoic acid also
mediates adhesion
- Extracellular Toxins of Group A
streptococci (includes Toxins,
Hemolysins, and Extracellular Enzymes)
- Streptococcal Pyrogenic Exotoxins
(Spe)
- Members of a family of
toxins that are closely
related including
staphylococcal
enterotoxin serotypes
A-F, staphylococcal
pyrogenic exotoxins A and
B, and staphylococcal
toxic shock syndrome
(TSS) toxin. Properties
of this family of toxins
include pyrogenicity and
effects on the immune
system.
- Invasive Group A strep
strains produce one or
more than one of three
different toxins
SPE A, SPEB, SPB C. Many
different combinations of
these exotoxins are
recovered from invasive
strains suggesting that
no single toxin is
responsible for toxic-
shock like syndrome
(TSLS).
- SPE A (erythrogenic
toxin, scarlet fever
toxin) is produced by
strains lysogenized with
a temperate
bacteriophage. Acts as a
superantigen.
- SPE B cysteine
protease that cleaves a
number of host proteins
including fibronectin and
vitronectin (2 abundant
extracellular matrix
proteins). This
proteolytic activity is
directly responsible for
the extensive tissue
damage seen in patients
with severe invasive and
toxic shock-like
syndrome., This enzyme
also cleaves human
interleukin-1 B precursor
to generate biologically
active IL-1B, suggesting
an important role in
inflammation and shock.
Evidence for its
importance in
pathogenesis:
- An inhibitor of
cysteine protease can
cure mice of an otherwise
lethal dose of S.
pyogenes.
- Immunization of mice
with cysteine protease
protects mice against
intraperitoneal
challenge.
- In patients with
recent invasive infection
there is a significant
association between lack
of antibody to SPE B and
more severe disease
course.
- SPE C
resembles SPE A in
several ways. Associated
with lysogeny; biological
effects similar to SPE B.
- Streptolysins S and O (hemolysins
responsible for beta hemolysis on
blood agar plates)
- Streptolysin O (oxygen
labile)
- Similar structure and
mechanism of action to
pneumolysin (S.
pneumoniae),
tetanolysin (C.tetani),
theta toxin (C.
perfngens),
cereolysin (B. cereus),
and lysteriolysin (L.
monocytogenes)
- Binds to cholesterol
on the cell surface
pore forming toxin
binds to the cell
membrane causing lysis of
leukocytes, platelets,
and erythrocytes
- Intravenous injection
into mice, rabbits and
guinea pigs causes death
within seconds! Death is
the result of an acute
toxic action on the
heart. Does this toxin
play a role in rheumatic
fever?
- Immunogenic
Serum antibodies to
streptolysin O are made
after streptococcal
infections. The more
severe the infection, the
higher the titers.
Highest titers in
rheumatic fever patients.
(See diagnosis below)
- Streptolysin S (oxygen
stable)
responsible for hemolysis
seen around colonies of
group A streptococci on
BAPs incubated
aerobically.
Nonimmunogenic.
Significance in vivo?
- Streptokinase (Fibrinolysin,
streptococcal spreading factor),
lyses blood clots and may
facilitate spread of bacteria in
tissues
- DNAse
- All strains of S.
pyogenes form at least
one DNAse
- Depolymerizes cell-free
DNA in purulent material
- C5a peptidase
- a surface-associated
serine protease produced
by all strains of S.
pyogenes
- Cleaves human C5a, one of
the main chemoattractants
of PMNs during
inflammation
- Hyaluronidase
- Produced by all strains
of S. pyogenes
- Believed to facilitate
invasion and spread of
bacteria
- A General Scheme for Group A Streptococcal
Pathogenesis (Review Falkows
Definition of a Pathogen and Mims
Obligatory Steps for Infectious Microbes and the
Introductory Lectures given in this course
(1-12)) Falkows definition of a pathogen
(transparency)
MIMs - Obligatory Steps for Infectious
Microorganisms (transparency)
Since Group A streptococci cause several
different types of diseases from
superficial infections such as impetigo (and
pharyngitis) to life threatening systemic disease
(such as necrotizing fasciitis and toxic shock),
the answer to these questions must be tailored to
fit the clinical presentation.
- EpidemiologyHow does a person acquire Group A
streptococci? What is the reservoir for these
organisms?
- Group A streptococci transiently
colonize the oropharynx and the skin.
Carriage rates in children estimated at
15-20% varying with the season.
- Disease is usually caused by a recently
acquired strain that can establish an
infection of the pharynx or skin before
specific antibodies (to the M protein)
are produced or competitive oranisms can
proliferate.
- Transmission
- Respiratory infections
person to person spread via
aerosols (droplets)
- Skin infections through
breaks in the skin after direct
contact with an infected person,
a fomite, or an arthropod vector
- Predisposing factors?
- Clinical Syndromes
- Pharyngitis (remember viruses are the
most common cause of acute pharyngitis)
- Characterized by pain, redness
and swelling of the posterior
pharynx, accompanied by a greyish
white tonsillar exudate,
tenderness of the cervical lymph
nodes, fever and general malaise
(see Case 1 in text p. 144)
- A common infection in school-aged
children.
- Usually self-limiting although
complications can occur:
- peritonsillar abscess
quinsy
- Otitis media, sinusitis,
mastoiditis, caused by
local spread of S.
pyogenes.
- Scarlet fever (see #2,
below)
- Sequelae - Rheumatic
fever (RF) and acute
glomerulonerphitis (AGN)
(discussed below)
- Diagnosis throat swab and
culture on BAP with
susceptibility to bacitracin;
rapid diagnostic tests based on
extraction of the group antigen
from throat swabs.
- Treatment - Penicillin is given
to prevent RF and AGN
- Scarlet Fever (See Handout: Patient 37 -
Infectious Disease Pearls)
- Certain strains of Group A strep
produce a pyrogenic exotoxin (SPE
A, scarlet fever toxin,
erythrogenic toxin) coded for by
a lysogenic bacteriophage.
- Signs and Symptoms- A few days
after the onset of pharyngitis, a
diffuse erythematous rash
(sandpaper texture) appears on
the upper chest and then spreads
to the extremities. Pathogenesis?
A yellowish white coating
initially covers the tongue and
is later shed, revealing a red,
raw surface beneath
"strawberry
tongue". The rash disappears
over the next 5 to 7 days and is
followed by superficial
desquamation of the skin. Rarely
seen a severe form of
scarlet fever associated with
high fever and systemic toxicity.
- Diagnosis made by positive throat
culture and the compatible
clinical features. Treatment is
the same as for streptcoccal
pharyngitis Penicillin
- Skin and Soft Tissue Infections (Range
from mild and self-limiting to life
threatening. As the text points out,
pharyngeal infections may be locally very
severe (with inflammation, abscess
formation, and even necrosis necrosis in
and around the tonsils), and there may be
occasional spread to the bloodstream
however, spread to adjacent tissues
is unusual. This contrasts with skin and
soft tissue infections. With the
exception of impetigo, which is a
localized infection, the other infections
of skin and soft tissues are highly
invasive infections which spread very
rapidly (virulence factors?) We will not
review the anatomy we talked about
previously see Lecture 24)
- Impetigo- superficial infection
of the dermis (caused by Strep
and Staph) that resolves
spontaneously in 1-2 weeks.
Begins as a pinpoint papule,
progresses to vesicles, which
become pustular and crust over.
Vesicles may rupture and
ulcerate.
- Epidemiology, Who gets
impetigo?
- associated with warm,
humid climates
- can occur in Northern
climates
pre-school children,
prison inmates, residents
of mental institutions,
and workers handling raw
meat.
- predisposing factor
poor hygiene
- pathogenesis
- The infection has
been studied
experimentally. Can
develop within 10 days of
skin colonization;
transfer to the nose and
throat can occur within
14 and 20 days
respectively following
initial skin
colonization.
- Lesions thought to
arise when colonizing
organisms are introduced
into broken skin via
minor trauma or insect
bites.
- Associated with
restricted M types
(different than those
that normally colonize
the pharyx)- display a
greater variety of M
types than throat
colonizing strains.
- The danger of
impetigo can be
followed by acute
glomerulonephitis (not
rheumatic fever).
- Erysipelas- an acute spreading
inflammation of the dermis.
Lesion is erythematous, swollen,
has a well defined edge, and may
be accompanied by symptoms of
fever and chills.
- Pathogenesis? Questions
you might ask to
understand the
pathogenesis of this
clinical presentation?
What is known:- Norrby
(1992) studied strains
isolated from erysipelas
- Predominance of M1
serotype
- Low level production
of erythrogenic toxin
(Spe A) but high level
production of Spe B and
Spe C.
- Higher frequency of
polymorphism in the genes
for the M protein.
- may be preceded by
URI or infection of
broken skin, or many
times etiology is
unknown.
- lesions usually
resolve in 2-14 days; not
uncommon for patients to
have repeated attacks in
the same area of skin.
- Cellulitis infection of
the subcutanous tissue caused
when streptococci gain access to
broken skin.
- Develops rapidly
progressing from minor
trauma to severe
septicemia in 24-48h.
- Rapidly spreading
inflammation
- localized symptoms of
pain, swelling and
redness of the skin (not
raised or clearly
demarcated like
erysipelas), may have
local desquamation of the
skin.
- accompanied by fever,
chills, lymphangitis
(inflammation of a
lymphatic vessel or node)
( indicative of
spreading!!), and
progressing to bacteremia
(blood cultures +).
- May be accompanied by
toxic shock
- Case studies about
cellulitis (Case 9 and
Patient 35)
- Who gets these
infections?
- Most are previously
healthy adults
- Predisposing factors
- children with
chickenpox
- women radical
mascetomy
recurrent arm cellulitis
- coronary bypass
patients recurrent
leg cellulitis
- Necrotizing fasciitis- "the
flesh eating infection"
deeper infection of the
soft tissue characterized by
extensive destruction of fat and
muscle that spreads along planes
of fascia.
- Symptoms
introduction of
streptococci into the
skin 24 h later,
the infection starts out
like cellulitis (redness
and swelling) although
the pain experienced
seems out of proportion
with the findings in the
tissue.
- Within 24-48 h the
erythema darkens to a
purplish than blue hue
and bullae appear.
Gangrene and systemic
symptoms then develop.
Unlike cellulitis, which
can be treated with
antibiotics alone,
necrotizing fasciitis
must be treated
aggressively with the
surgical debridement of
nonviable tissue.
- Severe streptococcal infection
accompanied by Stretococcal Toxic
Shock Syndrome (STSS). (See Case
study 64 on the Web and in the
Science Library)
- Necrotizing fasciitis and
STSS may occur together
and are the most serious
manifestations of
invasive GAS infection.
Common additional
symptoms are fever,
tachycardia and
hypotension. Shock, DIC,
renal failure and acute
respiratory distress
syndrome (multiorgan
system failure) follows.
In spite of appropriate
treatment - fatality rate
30-50%.
- If you compare TSS caused
by S. aureus, with STSS
caused by group A strep,
S. aureus is localized at
the site of infection (in
a tampon, or an infected
wound), while S. pyogenes
is invasive, moving from
the original site of
infection into the
bloodstream producing a
systemic infection
(bacteremia, septicemia,
+ blood cultures). Even
though these two
organisms produce similar
toxins, death rates are
10 fold higher for STSS
compared with TSS.
- Epidemiology
- Increasing in
frequency around the
world. Outbreaks of
disease, including Austin
(why?).
- Occurs most often in
previously healthy
adults.
- Predisposing
conditions (those with
increased risk)?
- 40% of children have
concurrent varicella
infections.
- Adults skin
disorders, chronic heart
and lung disease,
diabetes, and malignancy
(most common underlying
conditions).
- Pathogenesis? (You give
me the step by step
pathogenesis) How can you
explain the recent
increase in severe STSS?
Strains of S, pyogenes
with increased virulence?
(Virulent clones
associated with certain M
types cause outbreaks?
This was not the case in
Austin)
- Host factors?
- Predisposing factors?
- A susceptible host
population (without
antibodies against the M
protein or the Spe
toxins?). Host antibodies
to M protein will abort
infections, but
antibodies to Spe will
allow for invasive
infections but with less
severe disease.
- Bacterial virulence
factors? These rapid and
devastating infections
are associated with
certain M types (1,3, 18)
and with the Spe toxins (
Spe A and SpeB). How do
these toxins produce
shock and death?
- Other Suppurative Diseases
- Puerperal or childbed fever
Text Case 2, p. 144. A
historical case from 1846
Group A strep infections were the
cause of postpartum
endomyometritis and sepsis-
spread by the hands of physicians
who had performed autopsies and
then came and delivered babies
without washing their hands. One
of the first examples of
infection control when Ignaz
Semmelweiss required doctors to
disinfect their hands with
chloride of lime.
- Bacteremia
- Pneumonia
- Postreptococcal (Nonsuppurative) Diseases
Disorders in which local infection
with Group A strep is followed 1-4 weeks
later by inflammation in an organ that
was not infected with streptococci
- Rheumatic Fever- occurs when
preceded by pharyngitis
- Symptoms include fever,
malaise, polyarthritis,
and evidence of
inflammation of all parts
of the heart. Leads to
thickened and deformed
heart valves and
granulomas in the
myocardium which are
finally replaced by scar
tissue. Patients may
later develop subacute
bacterial endocarditis.
- Epidemiology
increasing since the mid
1980s, clusters
seen in school children
and military camps.
Associated with certain M
types ( the return of
strains able to cause the
condition?).
- Pathogenesis- due not to
bacterial infection of
the heart but to some
direct or indirect effect
of circulating bacterial
products. Hypotheses:
- Autoimmune
explanation-M protein
serotypes found on
rheumatogenic strains
have epitopes that that
cross react with epitopes
on cardiac mysoin. T
cells or antibodies that
recognize these epitopes
could attack heart tissue
and cause an inflammatory
response that damages
heart valves.
- Direct damage to
heart tissue by toxins.
- Glomerulonephritis- occurs when
preceded by pharyngitis or a skin
infection
- Symptoms: renal
glomerular damage,
hypertension,
hypertension, edema, and
proteinuria and hematuria
- Associated with
nephritogenic strains;
- Pathogenesis: Hypotheses
- Evidence supports
that renal damage is the
result of immune complex
deposition on the
glomerular basement
membrane and complement
activation that generates
a massive inflammatory
response.
- Direct damage to
kidney by toxins.
- Laboratory Diagnosis
- Microbiologic
- Specimens- throat swab, pus, or
blood, CSF, etc. is obtained for
culture. Serum is obtained for
antibody determination.
- Direct smears- not helpful for
throat swabs because hemolytic
streptococci are always present
and look the same as Group A
strep on stained smears. Are
helpful for other specimens.
- Antigen Detection Kits- for rapid
detection of group A strep from
throat swabs. Kits use enzymatic
or chemical methods to extract
antigens from the swab, then use
ELISA or agglutination tests to
demonstrate the presence of the
antigen. (60-90% sensitive and
98-99% specific when compared to
culture.)
- Culture- 2 BAPs incubated in 10%
CO2 and anaerobically. Look for
hemolysis and appearance of
colonies. Presumptive I.D.-
inhibition of growth by
bacitracin. Definitive I.D. with
direct FA test, or by rapid tests
specific for the group A
carbohydrate antigen.
- Serologic: A rise in titer of
anti-Streptolysin O antibodies (ASO).
- Treatment: All group A strep are sensitive to
penicillin G and most are sensitive to
erythromycin. Antimicrobial drugs have no effect
on established rheumatic fever or
glomerulonephritis. (This is why its important to
rapidly eradicate streptococci from the patient
with an acute streptococcal infection (before day
8). Group A strep infections are self- limiting
but patients are treated to prevent these late
sequelae.)
- Immunity Resistance against Group A strep disease
is correlated with antibody type specific
antibody production against the M protein.
Immunity to scarlet fever is against the specific
exotoxin that caused the rash. Immunity to skin
and puerperal sepsis disease does not occur.
Reoccurences of RF are frequent; any of the other
M serotypes can initiate the preceding
pharyngitis. Reocurrences of AGN are rare due to
the limited number of nephritogenic strains.
- Prevention and Control
- No available vaccine- problems include
multiple M protein types, and the
potential for cross reaction with shared
epitopes in the host.
- Control - Use penicillin to eliminate
cases and carriers during community
outbreaks. Chemopropylaxis for prevention
of recurrent rheumatic fever prior to
dental or other surgical procedures.
SEE CHAPTER 12 IN THE TEXT FOR DISCUSSION OF THE
STREPTOCOCCI OUTLINED BELOW:
- GROUP B STREPTOCOCCUS (S. agalactiae)
- Epidemiology :Inhabitants of the lower GI tract
and female genital tracts (vaginal colonization).
common).
- The etiological agent of:
- Postpartum and neonatal infections:
Neonatal sepsis and meningitis (the
leading cause). Transmission occurs from
mother to child at birth; isolated from
the mucous membranes and skin of
newborns.
- Cellulitis, arthritis and meningitis in
adults- usually seen in older adults with
predisposing conditions such as diabetes
mellitius, cancer and HIV infection.
- Virulence is associated with a polysaccharide
capsule (Serotype III associated with neonatal
disease)
- GROUP D STREPTOCOCCUS (Enterococci (S. faecalis is
now Enterococcus faecalis) and
Nonenterococci (S. bovis)
- Part of the normal flora of the gastrointestinal
tract.
- Text: "Enterococci - the worlds
toughest pathogen"; resistant to penicillin
and many antibiotics including vancomycin (VRE =
vancomycin resistant enterococci "the
nosocomial pathogen of the 90s").
Transfer of the gene for vancomycin resistance to
S. aureus demonstrated in the laboratory.
- Cause urinary, biliary and cardiovascular
infections (much lower virulence than other
streptococci).
- VIRIDANS STREPTOCOCCI (alpha hemolytic)
- Inhabitants of the normal oropharynx (make up
30-60% of the normal flora)
- Etiological agents of :
- Dental caries S. mutans
- Infective Endocarditis the heart
is seeded by bacteria during transient
bacteremia; infection involves the
endothelial lining of the heart, usually
the heart valves. (See Text chapter 64
and Case 36 Infectious Disease
Pearls)
- Infection of native heart valves
- Acute bacterial endocarditis
60% S. aureus
- Subacute bacterial endocarditis
- associated with viridans
streptococci (S.
sanguis, S. mutans,
and S. mitior).
- Pathogenesis -
streptococci enter the
bloodstream during a
dental procedure (teeth
cleaning) or flossing,
and adhere to aggregates
of platelets and fibrin
on damaged heart valves,
mutiply and attach
further fibrin and
platelet deposition. The
bacteria are protected
from host defenses and
can grow to several
centimeters in size. A
slow process
taking approx. 5 weeks
before symptoms appear.
- Symptoms - fever, a heart
murmur, and nonspecific
malaise.
- Blood culture most
important laboratory
test.
- Endocarditis in
Intravenous Drug users
S. aureus
- Prosthetic valve
endocarditis S.
epidermidis, S.
aureus, Gram negative
rods, and fungi
- THE MORTALITY OF
INFECTIVE ENDOCARDITIS IS
20- 30% DESPITE
ANTIBIOTIC TREATMENT.
Complete eradication can
take several weeks
because
- Organisms are
relatively inaccessible
within the vegetations
both to the antibiotics
and the host defenses
- Organisims grow to a
high population density,
and multiply relatively
slowly.